TLOG (TetraLogic Pharmaceuticals) ROIC %: -24.60% (As of Sep. 2016)


What is TetraLogic Pharmaceuticals ROIC %?

TetraLogic Pharmaceuticals TLOG ROIC % is -24.60% as of Sep. 2016.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. TetraLogic Pharmaceuticals's annualized return on invested capital (ROIC %) for the quarter that ended in Sep. 2016 was -24.60%.

As of today (2026-07-07), TetraLogic Pharmaceuticals's WACC % is 0.00%. TetraLogic Pharmaceuticals's ROIC % is 0.00% (calculated using TTM income statement data). TetraLogic Pharmaceuticals earns returns that do not match up to its cost of capital. It will destroy value as it grows.


TetraLogic Pharmaceuticals  (OTCPK:TLOG) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, TetraLogic Pharmaceuticals's WACC % is 0.00%. TetraLogic Pharmaceuticals's ROIC % is 0.00% (calculated using TTM income statement data). TetraLogic Pharmaceuticals earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


TetraLogic Pharmaceuticals ROIC % Related Terms


TetraLogic Pharmaceuticals ROIC % Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals ROIC % Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
ROIC %
-1,758.53 -1,939.09 -1,105.10 -95.38 -73.38

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -55.75 -74.70 -59.92 -33.67 -24.60

TLOG vs ARGSQ, GTHR, SOAN: ROIC % Comparison

For the Biotechnology subindustry, TetraLogic Pharmaceuticals's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TetraLogic Pharmaceuticals ROIC % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TetraLogic Pharmaceuticals's ROIC % distribution charts can be found below:

* The bar in red indicates where TetraLogic Pharmaceuticals's ROIC % falls into.



TetraLogic Pharmaceuticals ROIC % Calculation

TetraLogic Pharmaceuticals's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2015 is calculated as:

ROIC % (A: Dec. 2015 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2014 ) + Invested Capital (A: Dec. 2015 ))/ count )
=-38.5 * ( 1 - 0% )/( (62.789 + 42.149)/ 2 )
=-38.5/52.469
=-73.38 %

where

TetraLogic Pharmaceuticals's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Sep. 2016 is calculated as:

ROIC % (Q: Sep. 2016 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2016 ) + Invested Capital (Q: Sep. 2016 ))/ count )
=-15.044 * ( 1 - 21.16% )/( (50.591 + 45.823)/ 2 )
=-11.8606896/48.207
=-24.60 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2016) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of -24.60% mean?
TetraLogic Pharmaceuticals (TLOG) has a ROIC % of -24.60% as of Sep. 2016. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' ROIC % too high?
TetraLogic Pharmaceuticals' current ROIC % is -24.60%.
How does TetraLogic Pharmaceuticals' ROIC % compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' ROIC % of -24.60% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Biotechnology company?
A good ROIC % depends on the Biotechnology industry context. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current ROIC % is -24.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current ROIC % of -24.60%. The current ROIC % is -24.60%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current ROIC % is -24.60% as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.